CSat Investment Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.9M Buy
38,484
+38,397
+44,134% +$2.8M 2.43% 9
2020
Q4
$6K Sell
87
-57,436
-100% -$3.74M 0.01% 468
2020
Q3
$3.36M Buy
57,523
+36,246
+170% +$2.26M 0.3% 29
2020
Q2
$1.38M Buy
21,277
+18,998
+834% +$1.2M 0.17% 62
2020
Q1
$135K Buy
2,279
+399
+21% +$26.6K 0.03% 296
2019
Q4
$140K Buy
1,880
+91
+5% +$6.39K 0.04% 292
2019
Q3
$113K Buy
1,789
+113
+7% +$6.7K 0.04% 293
2019
Q2
$91K Buy
1,676
+1,443
+619% +$77.7K 0.03% 310
2019
Q1
$13K Buy
233
+194
+497% +$12K 0.01% 390
2018
Q4
$3K Buy
39
+5
+15% +$373 ﹤0.01% 515
2018
Q3
$3K Sell
34
-141
-81% -$10.1K ﹤0.01% 505
2018
Q2
$12K Buy
+175
New +$11.5K 0.01% 300

Other funds holding CVS

CSat Investment Advisory's CVS Position: Q1 2021 in Review

CSat Investment Advisory increased its CVS Health (CVS) stake by 44,134% in Q1 2021, buying an estimated $2.8M and bringing the position to 38,484 shares worth $2.9M. The position accounts for 2.43% of the portfolio, ranked #9.

CSat Investment Advisory first reported a position in CVS in Q2 2018 and has held it in 12 quarters since. The position peaked at $3.36M in Q3 2020. 2,033 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • CSat Investment Advisory held 38,484 shares of CVS Health worth $2.9M as of Q1 2021.
  • CSat Investment Advisory bought 38,397 CVS Health shares in Q1 2021, an estimated $2.8M.
  • CVS Health made up 2.43% of CSat Investment Advisory's portfolio in Q1 2021, its #9 holding.
  • CSat Investment Advisory first reported a position in CVS Health in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's CVS Health position peaked at $3.36M in Q3 2020.
  • 2,033 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.